PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences Post author:Cleo Sciscioli Post published:September 5, 2023 Post category:Newsroom PHAXIAM publie aujourd’hui sa trésorerie au 30 juin 2023 et son calendrier financier pour le second semestre 2023. You Might Also Like ERYTECH announces that the Commercial Court has rejected Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma June 14, 2023 ERYTECH Presents Findings at European Red Cell Research Society Meeting March 11, 2019 ERYTECH RAISES €10 MILLION IN PRIVATE PLACEMENT WITH U.S. AND EUROPEAN INVESTORS December 8, 2016
ERYTECH announces that the Commercial Court has rejected Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma June 14, 2023
